Lefamulin acetate (BC-3781 acetate) 是一种口服活性抗生素，用于 community-acquired bacterial pneumonia (CABP) 治疗。Lefamulin acetate (BC-3781 acetate) 是第一种用于人体细菌感染的全身治疗的半合成截短侧耳素。Lefamulin acetate (BC-3781 acetate) 通过与 50S 细菌核糖体的肽基转移酶 peptidyl transferase 中心结合来抑制蛋白质合成，从而阻止了转移RNA与肽转移的结合。
货号:ajcx16104
CAS:1350636-82-6
分子式:C30H49NO7S
分子量：567.78
溶解度:DMSO: ≥ 100 mg/mL (176.12 mM); H2O:< 0.1 mg/mL (insoluble)
纯度：98%
存储：Store at -20°C
库存：现货

Background:

Lefamulin acetate (BC-3781 acetate) is an orally active antibiotic for community-acquired bacterial pneumonia (CABP) treatment. Lefamulin acetate (BC-3781 acetate) is the first semi-synthetic pleuromutilin for systemic treatment of bacterial infections in humans. Lefamulin acetate (BC-3781 acetate) inhibits protein synthesis by binding to the peptidyl transferase center of the 50S bacterial ribosome, preventing the binding of transfer RNA for peptide transfer[1].

[1]. Veve MP, et al. Lefamulin: Review of a Promising Novel Pleuromutilin Antibiotic. Pharmacotherapy. 2018 Sep;38(9):935-946. doi: 10.1002/phar.2166. Epub 2018 Aug 20.